ACTH versus vigabatrin therapy in infantile spasms: A retrospective study

Neurology

Volumn 52, Issue 8, 1999, Pages 1691-1694

  Cossette, Patrick ^a,c   Riviello, James J ^b,c   Carmant, Lionel ^a,c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; VIGABATRIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; INFANT; INFANTILE SPASM; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033549104     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.8.1691     Document Type: Article

References (10)

1. Hrachovy RA, Frost JD, Kellaway P, Zion T. A controlled study of ACTH therapy in infantile spasms. Epilepsia 1980;21: 631-636.
2. Siemes H, Spohr HL, Michael TH, Nau H. Therapy of infantilespasms with valproate: results of a prospective study. Epilepsia 1988;29:553-560.
3. Dreifuss F, Farwell J, Holmes G, et al. Infantile spasms: comparative trial of nitrazepam and corticotropin. Arch Neurol 1986;43:1107-1110.
4. Blennow G, Starck L. High dose Be treatment in infantile spasms. Neuropediatrics 1986;17:7-10.
5. Lombroso CT. A prospective study of infantile spasms: clinical and therapeutic correlations. Epilepsia 1983;24:135-158.
6. Jeavons PM, Bower BD, Dimitrakoudi M. Long-term prognosis of 150 cases of "West syndrome." Epilepsia 1973;14:153-164.
7. Aicardi J, Sabril IS, Investigator and Peer Review Groups, et al. Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Epilepsia 1996;37:638-642.
8. Vigevano F, Cilio MR. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia 1997;38:1270-1274.
9. Chiron C, Dumas C, Jambaque I, et al. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 1997;26:389-395.
10. Frye CA. The neurosteroid 3 alpha, 5 alpha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res 1995;696:113-120.